Pfizer’s mRNA Flu Vaccine Works, But Politics May Block It
Pfizer’s experimental mRNA flu vaccine demonstrated significantly better protection against influenza in a large Phase III trial. The vaccine reduced flu cases by 34.5% compared to traditional shots, but faces political hurdles from RFK Jr.’s anti-mRNA campaign that’s already delayed similar vaccine